Seya Industries Ltd Q2 Loss Narrows to ₹0.02 Crore Under CIRP
Key highlights
- Seya Industries reported a Q2 FY27 net loss of ₹0.02 crore versus a ₹0.93 crore loss in Q2 FY26.
- Q2 FY27 revenue from operations was nil, while other income was ₹4.65 crore.
- H1 FY27 net loss narrowed to ₹0.73 crore from ₹1.55 crore a year earlier.
- The Venus India Asset-Finance 51% acquisition long-stop date was extended to March 31, 2027.
powered by IRIS

Seya Industries Ltd reported a net loss of ₹0.02 crore for the quarter ended September 30, 2026, compared with a ₹0.93 crore loss a year earlier, while revenue from operations remained nil. The specialty chemicals company is under the Corporate Insolvency Resolution Process, and its ₹4.65 crore quarterly income came entirely from other income.
Know Seya Industries inside out
Results, valuation, peers and who's buying, in one view.
What did Seya Industries report for Q2 FY27?
Seya Industries reported unaudited standalone results for Q2 FY27 with total income of ₹4.65 crore, up from ₹3.81 crore in Q2 FY26. The company recorded no revenue from operations in either period, meaning that all reported quarterly income was classified as other income.
The net loss narrowed to ₹0.02 crore from ₹0.93 crore in the corresponding quarter of the previous year. Loss before tax was ₹0.57 crore, compared with ₹1.44 crore a year earlier. A tax credit of ₹0.55 crore reduced the reported loss after tax for the quarter.
The quarterly operating margin was negative 12.8%, compared with negative 36.8% in Q2 FY26 and negative 34.2% in Q1 FY27. Since the company did not report operating revenue, the margin metric should be read alongside the continuing absence of sales activity.
Why is Seya Industries operating under CIRP?
Seya Industries is undergoing the Corporate Insolvency Resolution Process, or CIRP, following an order of the National Company Law Tribunal, Mumbai, dated November 2, 2023. Under this process, the company’s affairs are managed through the insolvency framework rather than by its regular board-led management structure.
The Q2 FY27 standalone results were reviewed by an independent committee and approved by the interim resolution professional, or IRP, on November 14, 2026. The filing identifies the results as unaudited, which is relevant for investors assessing the company’s current financial disclosures.
The company’s reported financial position continues to reflect the operational constraints associated with the insolvency process. No operating revenue was recorded for the quarter or for the half year ended September 30, 2026, indicating that the improvement in the quarterly loss did not come from a resumption of sales.
What were the half-year financial results?
Seya Industries recorded total income of ₹8.49 crore for the first half of FY27, against ₹9.03 crore in the corresponding half of FY26. As in the second quarter, the half-year income was reported entirely as other income, with revenue from operations remaining nil.
The H1 FY27 net loss narrowed to ₹0.73 crore from ₹1.55 crore a year earlier. Basic and diluted loss per share for the half year was ₹0.28. The lower loss provides a year-on-year improvement in the reported result, but the company remains loss-making and has not reported operating sales.
Depreciation was a significant cost item in the September quarter at ₹4.45 crore. Employee benefit expense was ₹0.40 crore. These expenses continued to exceed the company’s total income and contributed to the loss before tax despite the higher other income reported during the quarter.
Got a follow-up? Ask IRIS
How do the results affect investors and operations?
The results show a substantially smaller Q2 loss, but the reported improvement is linked to other income and a tax credit rather than operating revenue. For investors, the continued absence of sales remains a central factor because it limits the ability to assess the underlying performance of the specialty chemicals business through normal operating metrics.
Seya Industries was quoted at ₹11.70 in the supplied market data and was identified as a micro-cap company in the specialty chemicals sector. The information provided does not state a share-price reaction to the results. The financial filing instead places the focus on the company’s CIRP status, nil revenue from operations, and the loss reduction in the reported period.
For employees, creditors, customers and other stakeholders, the resolution process is the key operating context. The quarterly filing does not disclose a restart of production or sales, and it does not provide a new operating-revenue target. As a result, the reported income and loss figures should be considered in the context of an entity still undergoing insolvency resolution.
What is the significance of the Venus India Asset-Finance deadline?
Seya Industries’ board extended the long-stop date for the proposed acquisition of a 51% stake in Venus India Asset-Finance to March 31, 2027. A long-stop date is generally the final date by which specified transaction conditions must be met or waived under the relevant agreement.
The disclosed extension gives the parties more time under the proposed transaction timetable. However, the supplied information does not state that the acquisition has been completed, nor does it quantify its potential financial effect on Seya Industries. It should therefore be treated as an unresolved corporate development rather than an established change in operations.
The extension is relevant because it is one of the few disclosed future milestones alongside the CIRP process. Its eventual status could matter to investors assessing the company’s corporate structure and strategy, but the Q2 FY27 filing itself continues to show no revenue from the existing operating business.
Conclusion
Seya Industries’ Q2 FY27 result showed a net loss of ₹0.02 crore, sharply narrower than the ₹0.93 crore loss in Q2 FY26, as total income increased to ₹4.65 crore. Yet revenue from operations stayed at nil, and the income reported in the quarter came wholly from other income while the company remained under CIRP.
Investors will next watch for developments in the insolvency resolution process, any evidence of operating revenue returning, and progress on the proposed Venus India Asset-Finance transaction. The disclosed long-stop date for the 51% acquisition has been extended to March 31, 2027.


